This compound is a chiral pharmaceutical intermediate specifically used in the manufacturing process of darolutamide. It features a pyrazole ring substituted with an aminopropyl group and a chlorobenzonitrile moiety.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1297537-41-7
3-acetyl-1H-pyrazole-5-carboxylic acid
pharmaceutical intermediate
Di-tert-butyl (2-oxopropane-1,3-diyl)dicarbamate
synthetic intermediate for midazolam impurities
Tert-butyl (3R,5S)-3,5-dimethylpiperazine-1-carboxylate
Pharmaceutical intermediate
Ethyl Piperazine-2-carboxylate Dihydrochloride
Pharmaceutical intermediate
Tert-Butyl (S)-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)carbamate
Pharmaceutical intermediate
Celecoxib N-des(benzenesulfonamide)
Pharmaceutical intermediate impurity
2-Chloro-4-(1H-pyrazol-3-yl)benzonitrile
pharmaceutical intermediate
4-[1-[(2S)-2-aminopropyl]pyrazol-3-yl]-2-chlorobenzonitrile
MQWGPHFTKXGETE-VIFPVBQESA-N
C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)N
—